Rhonda Farnum
Chief Tech/Sci/R&D Officer bij THERAVANCE BIOPHARMA, INC.
Vermogen: 3 M $ op 31-03-2024
Profiel
Ms. Rhonda F.
Farnum is a Chief Business Officer & SVP-Medical Affairs at Theravance Biopharma, Inc. Ms. Farnum was previously employed as a Head-Hematology Business Unit by Onyx Pharmaceuticals, Inc. She received her undergraduate degree from the University of Georgia.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
THERAVANCE BIOPHARMA INC
0.73% | 02-04-2024 | 349 233 ( 0.73% ) | 3 M $ | 31-03-2024 |
Actieve functies van Rhonda Farnum
| Bedrijven | Functie | Begin |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Rhonda Farnum
| Bedrijven | Functie | Einde |
|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01-08-2015 |
Opleiding van Rhonda Farnum
| University of Georgia | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
